ESPR (STOCKS)
Esperion Therapeutics, Inc.
$3.159700
+0.009700 (+0.31%)
Prev close: $3.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sheldon L. Koenig
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $814.31M
- Employees
- 304
- P/E (TTM)
- -30.43
- P/B (TTM)
- -2.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
8
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.10 | $-0.03 | -0.0658 | -192.40% |
|
Dec 2025 (Q4)
|
$0.22 | $0.25 | -0.0257 | -10.46% |
|
Sep 2025 (Q3)
|
$-0.16 | $-0.06 | -0.1036 | -183.69% |
|
Jun 2025 (Q2)
|
$-0.02 | $-0.15 | +0.1283 | +86.51% |
Financial Statements
| Revenues | $418.24M |
| Benefits Costs and Expenses | $423.98M |
| Costs And Expenses | $423.57M |
| Operating Expenses | $342.46M |
| Selling, General, and Administrative Expenses | $165.91M |
| Other Operating Expenses | $176.54M |
| Operating Income/Loss | $75.79M |
| Income/Loss From Continuing Operations After Tax | -$7.42M |
| Income/Loss From Continuing Operations Before Tax | -$100.84M |
| Income Tax Expense/Benefit | $1.84M |
| Net Income/Loss | -$7.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.00 |
| Diluted Earnings Per Share | -$0.00 |
| Basic Average Shares | 263,090,218 |
| Diluted Average Shares | 263,090,218 |
| Assets | $462.53M |
| Current Assets | $459.46M |
| Inventory | $104.21M |
| Other Current Assets | $355.25M |
| Noncurrent Assets | $3.07M |
| Fixed Assets | $311.00K |
| Other Non-current Assets | $2.76M |
| Liabilities | $770.46M |
| Current Liabilities | $300.36M |
| Accounts Payable | $68.41M |
| Wages | $6.94M |
| Other Current Liabilities | $225.02M |
| Noncurrent Liabilities | $470.10M |
| Equity | -$307.93M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$307.93M |
| Liabilities And Equity | $462.53M |
| Net Cash Flow From Operating Activities | -$18.19M |
| Net Cash Flow From Operating Activities, Continuing | -$18.19M |
| Net Cash Flow From Investing Activities | -$53.41M |
| Net Cash Flow From Investing Activities, Continuing | -$53.41M |
| Net Cash Flow From Financing Activities | $59.90M |
| Net Cash Flow From Financing Activities, Continuing | $59.90M |
| Net Cash Flow | -$11.69M |
| Net Cash Flow, Continuing | -$11.69M |
| Comprehensive Income/Loss | -$7.42M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.42M |
| Other Comprehensive Income/Loss | $5.30M |